Apogee Therapeutics, Inc. ( (APGE)) has released its Q3 earnings. Here is a breakdown of the information Apogee Therapeutics, Inc. presented to its investors. Apogee Therapeutics, Inc. is a ...

As of September 30, 2024, Apogee had cash, cash equivalents and marketable securities of $753.8 million. Apogee expects that its existing cash will enable it to fund its current operating expenses ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Vivani Medical, Inc. ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, long-acting drug implants, today reported financial results for the third quarter ended September ...

At Mar-a-Lago, ‘Uncle’ Elon Musk Puts His Imprint on the Trump Transition He’s on the patio. He’s on the golf course. Everywhere President-elect Trump looks, there is the world’s richest ...

DelveInsight's multiple sclerosis pipeline report depicts a robust space with 75+ active players working to develop 80+ pipeline therapies for multiple sclerosis treatment. Key multiple sclerosis ...